ArticleExperimental and therapeutic medicine2018

Blocking of the EGFR-STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinoma.

Changhe Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.